News

Harmoni Raises $10M Series A, Launches HAL Factory AI

Akron, Ohio – September 13, 2026 -- Harmoni, a Factory Orchestration platform for manufacturers, has raised $10 million in Series A funding led by Bessemer Venture Partners, the company announced. Alongside the raise, Harmoni unveiled HAL, an AI system designed to deliver context-aware intelligence directly to the factory floor.

Manufacturers face a projected shortfall of 3.8 million workers by 2033

Nearly half of those U.S. manufacturing positions risk going unfilled as reshoring initiatives and rising costs compound labor pressure, according to Harmoni. Founded in 2023 by David Caputo and Adam Ellis, the company built its platform to address fragmented factory-floor execution that persists despite heavy investment in ERP systems, machine connectivity, and automation.

Cyware Joins DOE-Funded NRECA Push to Expand OT Threat Monitoring

New York – September 13, 2026 -- Cyware is backing a Department of Energy-funded initiative led by the research arm of the National Rural Electric Cooperative Association (NRECA) to expand Operational Technology (OT) monitoring across nearly 900 electric cooperatives nationwide.

NRECA targets standardized threat data across rural utility networks

The project, run under NRECA's ICS-REC program, aims to standardize the collection, correlation and normalization of OT security data from participating rural cooperatives, enabling centralized analysis and faster threat detection across the grid.

Transcenta Licenses HiCB Bioprocessing Tech to WuXi Biologics

Suzhou – September 13, 2026 -- Transcenta Therapeutics has licensed its Highly Intensified Continuous Bioprocessing (HiCB) platform to WuXi Biologics under a non-exclusive technology agreement, securing an upfront payment of RMB 10 million plus future milestone payments.

Transcenta and subsidiary HJB grant WuXi Biologics non-exclusive rights to HiCB and ExcelPro media

Under the deal, Transcenta and its subsidiary HJB will license certain technologies tied to the HiCB continuous bioprocessing platform and its ExcelPro cell culture media to WuXi Biologics and its affiliates. WuXi Biologics will become a strategic CMC development partner supporting molecules across Transcenta's pipeline.

Findhelp Becomes First Registered Specialty Exchange Under Maryland MHCC

Austin, Texas – September 13, 2026 -- Findhelp has become the first specialty exchange to register with the Maryland Health Care Commission (MHCC), enabling social care referral and reporting support for the state's Rural Health Transformation Program (RHTP).

Findhelp registers as Maryland's first specialty exchange under MHCC oversight

The registration allows Findhelp to help RHTP grant awardees manage social risk screening, referrals, data exchange, and reporting requirements. Health care providers and community-based organizations (CBOs) gain specialized technical capabilities intended to reduce barriers in care coordination for rural patients.

Albaron Partners Sells Prime Psychiatry to Beacon Behavioral Partners

New York – September 13, 2026 -- Albaron Partners, LP has completed the sale of Texas-based Prime Wellness LLC, doing business as Prime Psychiatry, to Beacon Behavioral Partners, ending a four-year buildout of the outpatient and interventional psychiatry provider.

Albaron built Prime Psychiatry into a regional platform since 2022

Albaron partnered with founder Dr. Efosa Airuehia in 2022 to scale Prime Psychiatry across the Dallas-Fort Worth and Austin metro areas. The practice treats children, adolescents, and adults, offering anxiety and depression treatment, medication management, TMS, and Spravato therapy.

Avo Expands MEDITECH Alliance With Chart Assist, Ask Avo Tools

New York – September 13, 2026 -- Avo has expanded its MEDITECH Alliance partnership, adding Chart Assist and Ask Avo to its existing AI Scribe integration, giving MEDITECH Expanse health systems access to its full clinical AI platform inside the EHR.

Avo adds two AI tools to its MEDITECH Alliance partnership

Chart Assist synthesizes patient charts, flags care gaps, evaluates discharge readiness, and automates documentation across inpatient, emergency department, and outpatient settings. Ask Avo pairs live patient data with DynaMed medical evidence to answer clinical questions and draft documentation at the point of care. Both now join AI Scribe, Avo's ambient documentation tool that converts patient-provider conversations into structured, reimbursement-ready notes.

Clearway Health Names Rishi Seth Chief Operating Officer

Boston – September 13, 2026 -- Clearway Health has appointed Rishi Seth as chief operating officer, adding a 20-year healthcare operations veteran to its executive leadership team as the specialty pharmacy sector undergoes rapid change.

Seth brings two decades of healthcare integration experience to Clearway Health

Seth most recently served as senior vice president of integration at Millennium Physician Group, one of the largest independent physician groups in the United States, where he led integration of new provider groups and strategic partnerships. He previously held senior leadership positions at Optum Health and Privia Health, focusing on multidisciplinary scalability across clinical operations, finance, technology, human resources and revenue cycle functions.

SlimSEB Ingredient Cuts Glucose Spike 16.9% in Clinical Trial

Chino, Calif. – September 13, 2026 -- Specialty Enzymes & Probiotics has published dual-track research showing its ingredient SlimSEBTM reduces post-meal blood sugar spikes by 16.90% in a controlled human clinical trial, providing formulators with clinically backed data for glucose-support supplements.

Clinical trial confirms 16.90% reduction in glucose AUC

In a double-blind, randomized, placebo-controlled crossover trial, subjects supplemented with SlimSEBTM showed a 16.90% reduction in Area Under the Curve (AUC), a standard measure of post-prandial glycemic response. The result demonstrates statistically significant improvement in blood sugar control following meals.

Cheche Group Eyes $490M Stake in Solar-Storage Firm Long Way Fortune

Beijing – September 13, 2026 -- Cheche Group Inc. (Nasdaq: CCG) has signed a non-binding term sheet to make a strategic investment in Long Way Fortune, a residential solar-plus-storage operator active in Australia and Singapore, at an implied equity value of $490 million.

Cheche targets initial 20% stake with option to reach 51% ownership

The proposed stock-for-stock deal would give Cheche an initial 20% minority position in Long Way Fortune, with the option to raise its stake to as much as 51% over time subject to performance milestones and agreed conditions. Cheche's consideration will be stock-linked and released on a delayed schedule over several years.

Canam Steel Launches CrossBite Deck Fastening Tool for Faster Installs

Point of Rocks, Md. – September 13, 2026 -- Canam Steel Corporation (CSC) has launched CrossBite, a proprietary pneumatic side lap connection tool designed to cut jobsite labor costs by requiring fewer total connection points than screws or welds on steel deck installations.

CSC pairs joists and decking with a new proprietary fastening tool

The launch gives CSC a single-source package combining joist fabrication, deck manufacturing, and now CrossBite, a tool built specifically for steel deck applications facing high shear and stiffness demands. Michael Martignetti, Chief Commercial Officer of CSC, said the tool lets the company offer deck solutions in areas with high lateral loads while allowing customers to economize designs by reducing connection counts or lightening deck gage.

Subscribe to News